Cargando…
Hematopoietic Stem Cell Transplantation Stabilizes Cerebral Vasculopathy in High-Risk Pediatric Sickle Cell Disease Patients: Evidence From a Referral Transplant Center
BACKGROUND: Severe sickle cell disease (SCD) can present with different vaso-occlusive manifestations with cerebral vasculopathy (CV) as one of the most serious complications. Hematopoietic stem cell transplant (HSCT) is the ultimate therapy for this complication. The aim of this study was to assess...
Autores principales: | Al-Jefri, Abdullah, Siddiqui, Khawar, Al-Oraibi, Amira, Al-Seraihy, Amal, Al Ahmari, Ali, Ghemlas, Ibrahim, Al Anazi, Awatif, Al Saedi, Hawazen, Ayas, Mouhab |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elmer Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8929199/ https://www.ncbi.nlm.nih.gov/pubmed/35356638 http://dx.doi.org/10.14740/jh949 |
Ejemplares similares
-
Can the bone marrow harvest volume be reduced safely in hematopoietic stem cell transplantation with pediatric sibling donors?
por: AlAnazi, Awatif, et al.
Publicado: (2023) -
Clofarabine in Pediatric Acute Relapsed or Refractory Leukemia: Where Do We Stand on the Bridge to Hematopoietic Stem Cell Transplantation?
por: Ramiz, Sarah, et al.
Publicado: (2023) -
Pediatric high risk neuroblastoma with autologous stem cell transplant – 20 years of experience
por: Khan, Saadiya, et al.
Publicado: (2021) -
Outcomes of blood and marrow transplantation in children less than 2-years of age: 23 years of experience at a single center
por: Khan, Saadiya, et al.
Publicado: (2022) -
Outcome of pediatric chronic myeloid leukemia with management focusing on the monitoring of BCR-ABL fusion gene transcript levels
por: Al-Ghemlas, Ibrahim, et al.
Publicado: (2022)